Global & South-East Asia region typhoid researchers assembled in New Delhi, India on September 28-29 for the World Health Organization’s Informal Consultation of Experts in Typhoid Fever. The meeting reviewed global and regional enteric fever disease burden data as well as updated attendees on current studies in order to analyze the feasibility of various typhoid control strategies. Presentations were given on studies and new data in Bangladesh, India, Indonesia and Nepal. Also reviewed at the meeting was the typhoid conjugate vaccine (TCV) currently in development. The status of the TCV, knowledge about the performance of the currently available WHO prequalified vaccine, timelines for typhoid vaccine policy revision and activities to support TCV introduction were discussed in depth at the meeting.
With new data, multiple studies in progress and the TCV nearing pre-qualification, the WHO’s South East-Asia Regional Office (SEARO) used this consultation meeting as an opportunity to begin discussion for a regional plan aimed at (a) ensuring visibility of typhoid and paratyphoid fever as a priority public health problem; and (b) an agreed program for typhoid control in general and typhoid vaccine introduction specifically. A meeting report summarizing considerations for typhoid control and next steps towards development of a regional plan will be available soon from the WHO.
Meeting Attendees included:
Dr. Arindam Ray
Bill and Melinda Gates Foundation
Dr. Buddha Basnyat
Oxford University Clinic Research – Nepal International Clinic
Dr. Denise Garrett
Coalition against Typhoid, Sabin Vaccine Institute
Dr. Dipika Sur
Sabin Vaccine Institute
Dr. Enoka Corea
University of Colombo, Sri Lanka
Dr. Firdausi Qadri
International Centre for Diarrhoeal Disease Research (icddr, b)
Dr. Gagandeep Kang
Christian Medical College
Dr. Harish Iyer
Bill and Melinda Gates Foundation
Dr. Jacob John
Christian Medical College
Dr. Jamal Uddin
Dhaka Shishu Hospital
Dr. Jason Andrews
Stanford University
Dr. Kashmira Date
Center for Disease Control and Prevention
Dr. Krishna Mohan
Bharat Biotech International Ltd.
Dr. Mulya Rahma Karyanti
University of Indonesia
Dr. Namita Singh
Becton Dickinson India Pvt. Ltd
Dr. Narenda Kumar Arora
The INCLEN Trust International
Prof. Nirmal Kumar Ganguly
Translational Health Science and Technology Institute
Dr. Shanta Dutta
National Institute of Cholera and Enteric Diseases
Dr. Steve Luby
Stanford University
Dr. Vittal Mogasale
International Vaccine Institute
Dr. Pem Namgyal
WHO Regional Office for South-East Asia
Dr. Adwoa Bentsi-Enchill
WHO Headquarters
Dr. Nihal Abeysinghe
WHO Regional Office for South-East Asia
Dr. Sunil Bahl
WHO Regional Office for South-East Asia
Dr. Gopinath Nair
WHO Regional Office for South-East Asia
Dr. Mohammad Ahmad
WHO County Office, India
Dr. Pavana Murthy
WHO County Office, India
Dr. Aarti Garg
WHO Regional Office for South-East Asia
Mr. Rajiv Maken
WHO Regional Office for South-East Asia
